Key Takeaways
- Over 40 Italian centres participate in the BMH registry with harmonised metabolic endpoints.
- HbA1c, HOMA-IR and body composition are mandatory primary outcomes for every protocol.
- Data sharing reduces inter-site variability and enables robust meta-analyses.
From local data to national consensus
Endpoint fragmentation has long limited comparison between pilot studies. The BMH registry defines a core set of clinical, neurophysiological and quality-of-life variables, collected at standardised intervals at 4, 12 and 24 weeks.
Governance and data access
Data remain owned by participating centres, with aggregated access for accredited researchers. The BMH scientific committee quarterly reviews dataset quality and publishes open reports on the project platform.
"Standardising does not mean uniform clinical practice: it means making evidence comparable."
— Prof. Elena Rossi, University of Milan
Prof. Elena Rossi
Full Professor of Clinical Neuroscience at the University of Milan. Director of the BMH Neuromodulation Lab. Her research focuses on non-invasive brain stimulation for metabolic and psychiatric disorders. She has authored over 80 peer-reviewed publications and led 6 multicentre clinical trials.